Tarek Hammoud - Nov 17, 2022 Form 4 Insider Report for Enfusion, Inc. (ENFN)

Role: 10%+ Owner
Signature: /s/ Tarek Hammoud
Stock symbol: ENFN
Transactions as of: Nov 17, 2022
Transactions value $: $0
Form type: 4
Date filed: 11/21/2022, 04:45 PM
Previous filing: Nov 15, 2022
Next filing: Mar 10, 2023

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	ENFN	Class A Common Stock	Conversion of derivative security		+1.87M			1.87M	Nov 17, 2022	See footnote	F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	ENFN	Common Units of Enfusion Ltd. LLC	Conversion of derivative security	$0	-1.87M	-17.21%	$0.00	9M	Nov 17, 2022	Class A Common Stock	1.87M		See Footnote	F1, F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Common Units of Enfusion Ltd. LLC, and the corresponding shares of Class B common stock are exchangeable for shares of the issuer's Class A common stock on a one-for-one basis with the issuer having the ability to elect to pay cash in lieu of issuing Class A common stock.
F2	These Common Units are held by LRA Ventures, LLC. Tarek Hammoud is the sole manager of LRA Ventures, LLC, an estate planning vehicle. Mr. Hammoud may be deemed to have dispositive power over the securities held by LRA Ventures, LLC. Mr. Hammoud disclaims beneficial ownership of such securities except to the extent of his pecuniary interest therein.